CellSource Co

CellSource Co Shares Outstanding

The The number of shares of CellSource Co (4880.T) as of Oct 27, 2026 is 19.83 M. In the previous year, The number of shares was 19.83 M — a change of 0.00% (lower).

Shares Outstanding

19.83 M

YoY

0.00%

Last updated:

In 2025, CellSource Co had 19.83 M outstanding stocks, a 0.00% change from the 19.83 M stocks in the previous year.

The CellSource Co Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2022
19.83 M JPY
Jan 1, 2023
19.83 M JPY
Jan 1, 2024
19.83 M JPY
Jan 1, 2025
19.83 M JPY
Jan 1, 2026 (e)
19.82 JPY
Jan 1, 2027 (e)
19.82 JPY
Jan 1, 2028 (e)
19.82 JPY
Jan 1, 2029 (e)
19.82 JPY
The CellSource Co Shares Outstanding history
YEARShares OutstandingYoY
est19.820.00%
est19.820.00%
est19.820.00%
est19.82-100.00%
19.83 M0.00%
19.83 M0.00%
19.83 M0.00%
19.83 M0.00%
19.83 M0.00%
19.83 M0.00%
19.83 M0.00%
19.83 M0.00%
19.83 M—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Number of shares

CellSource Co shares outstanding

The number of shares of CellSource Co was 19.82 M in 2025. This indicates how many shares CellSource Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2022
19.21 M Stocks
Jan 1, 2023
19.40 M Stocks
Jan 1, 2024
19.81 M Stocks
Jan 1, 2025
19.82 M Stocks
Jan 1, 2026 (e)
19.82 M Stocks
Jan 1, 2027 (e)
19.82 M Stocks
Jan 1, 2028 (e)
19.82 M Stocks
Jan 1, 2029 (e)
19.82 M Stocks

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating CellSource Co's Shares Outstanding

CellSource Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in CellSource Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding CellSource Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in CellSource Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about CellSource Co stock

The number of shares of CellSource Co is 19.83 M in 2025.

The number of shares of CellSource Co changed from 19.83 M to 19.83 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares CellSource Co since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — CellSource Co

All Key Metrics — CellSource Co